OCD dTMS

BrainsWay OCD therapy can significantly improve OCD symptoms, as was demonstrated in the positive results of the BrainsWay’s Deep TMS study, the only multicenter trial in OCD patients ever conducted. The multicenter study demonstrated that after six weeks of treatment, there was a statistically significant improvement in the primary endpoint results for the active treatment group when compared to sham (p=0.0127).

The improvement was maintained one month after the end of treatment at week 10. The primary outcome measure of this study was the OCD Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), the gold standard measure of OCD symptom severity. Importantly, 38.1% of patients in the active group achieved a response of more than 30% reduction in symptom severity as measured by Y-BOCS, compared with just 11.1% in the sham group (p=0.0033). Moreover, 54.8% of patients in the active group achieved a partial response of more than 20% reduction in symptom severity versus just 26.7% in the sham group (p=0.0076).